Trademark: IMMUNE FORMULATION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
IMMUNE FORMULATION
Click here to search for trademarks similar to IMMUNE FORMULATION
Proof of use for IMMUNE FORMULATION
We do not have any records of a proof of use for IMMUNE FORMULATION at this moment.
Possible trademark infringements of IMMUNE FORMULATION
Basic Information about IMMUNE FORMULATION
- Serial Number
- 97695867
- Filing Date
- 29 Nov 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of IMMUNE FORMULATION on the blockchain with WikiTrademarks.io.
- First use of IMMUNE FORMULATION anywhere
- IMMUNE FORMULATION was first used on 30 Nov 2007 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns IMMUNE FORMULATION?
1. The Prolmmune Company, L.L.C. Rhinebeck NY
Correspondent
- John W. McGlynn Buchanan Ingersoll & Rooney, P.C.
- 2200 Renaissance Boulevard
- Suite 350
- King of Prussia, PA 19406
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io